Skip to main content
. 2021 Jul 5;12:608270. doi: 10.3389/fneur.2021.608270

Table 2.

Factors associated with favorable outcome.

Univariable Multivariable
Favorable outcome (n = 116) Unfavorable outcome (n = 68) p-value Odds ratio* (95% CI) p-value
Age, years 64.2 (± 14.8) 74.1 (± 9.9) <0.001 0.95 (0.91–0.99) 0.018
Male 76 (65.5) 30 (44.1) 0.005 0.79 (0.30–2.08) 0.636
Hypertension 78 (67.2) 49 (72.1) 0.514
Diabetes 28 (24.1) 25 (36.8) 0.091 0.69 (0.24–1.98) 0.488
Hypercholesterolemia 28 (24.1) 22 (32.4) 0.235
Smoking 44 (37.9) 11 (16.2) 0.002 3.19 (0.97–10.5) 0.056
Coronary artery disease 5 (4.3) 6 (8.8) 0.334
Atrial fibrillation 10 (8.6) 11 (16.2) 0.150 0.45 (0.11–1.88) 0.275
Initial NIHSS score 13.0 [8.0; 16.0] 16.0 [12.0; 20.0] <0.001 0.90 (0.82–0.98) 0.017
Occlusion site 0.903
  Internal carotid artery 28 (24.1) 17 (25.0)
  Middle cerebral artery 88 (75.9) 51 (75.0)
Use of IV tPA 45 (38.8) 18 (26.5) 0.108 1.69 (0.62–4.66) 0.308
Time of onset to puncture, min 320 [239; 609] 290 [202; 710] 0.631
Total procedure time, min 94 [60; 157] 104 [84; 147] 0.781
Frontline MT modality 0.024
  Stent retriever 106 (91.4) 54 (79.4) Reference
  Contact aspiration 10 (8.6) 14 (20.6) 0.71 (0.15–3.30) 0.667
No. of MT passes 2.2 (± 1.0) 3.5 (± 2.1) <0.001 0.47 (0.31–0.71) <0.001
Endovascular modalities <0.001
  MT alone 7 (6.0) 17 (25.0) Reference
  MT-RS 11 (9.5) 14 (20.6) 1.41 (0.07–27.9) 0.822
  MT-GPI 55 (47.4) 29 (42.6) 3.21 (0.44–23.5) 0.250
  MT-RS+GPI 43 (37.1) 8 (11.8) 20.4 (1.97–211.4) 0.012
Successful recanalization 113 (97.4) 55 (80.9) <0.001 8.48 (1.01–71.8) 0.049
Patent artery on follow-up 109 (94.0) 42 (61.8) <0.001 14.1 (2.05–97.4) 0.007
Postprocedural antithrombotics <0.001
  None 18 (15.5) 34 (50.0) Reference
  Oral antiplatelets immediately after procedure 8 (6.9) 6 (8.8) 1.62 (0.26–9.96) 0.603
  IV GPI infusion followed by oral antiplatelets 90 (77.6) 28 (41.2) 22.8 (1.09–475.9) 0.044

IV tPA, intravenous tissue plasminogen activator; MT, mechanical thrombectomy; MT-RS, rescue stenting after mechanical thrombectomy failure; MT-GPI, glycoprotein IIb/IIIa infusion after mechanical thrombectomy failure; MT-RS+GPI, rescue stenting with glycoprotein IIb/IIIa infusion after mechanical thrombectomy failure; IV GPI, intravenous glycoprotein IIb/IIIa inhibitor; NIHSS, National Institutes of Health Stroke Scale.

Values in parentheses represent the standard deviation or the number of patients (%). Brackets represent first and third quartiles.

*

Odds ratio for favorable outcome.